Genetic, cellular and immune approaches to disease therapy: past and future.
about
Rapid generation of a mouse model for Middle East respiratory syndrome.Protective effect of DNA vaccine encoding pseudomonas exotoxin A and PcrV against acute pulmonary P. aeruginosa InfectionHIV-1-based defective lentiviral vectors efficiently transduce human monocytes-derived macrophages and suppress replication of wild-type HIV-1Facilitated replacement of Kupffer cells expressing a paraoxonase-1 transgene is essential for ameliorating atherosclerosis in mice.Bioreducible polymers for therapeutic gene deliveryMolecular imaging of RNA interference therapy targeting PHD2 for treatment of myocardial ischemia.Mesenchymal stem cell-based NK4 gene therapy in nude mice bearing gastric cancer xenografts.Correction of hemophilia as a proof of concept for treatment of monogenic diseases by fetal spleen transplantation.Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis.Cross-species immunity in malaria vaccine development: two, three, or even four for the price of one?Redirecting adaptive immunity against foreign antigens to tumors for cancer therapy.Translational mini-review series on vaccines: Dendritic cell-based vaccines in renal cancer.Gene therapy in the treatment of heart failure.Biocomposites reinforced by fibers or tubes as scaffolds for tissue engineering or regenerative medicine.Enhancement of nasal HIV vaccination with adenoviral vector-based nanocomplexes using mucoadhesive and DC-targeting adjuvants.Adenoviral vector-mediated RTVP-1 gene-modified tumor cell-based vaccine suppresses the development of experimental prostate cancer.Influence of culture medium on the production of eif antigen from Leishmania chagasi in recombinant Escherichia coli.Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: implications for clinical efficacy.Selective unresponsiveness to beta cell autoantigens after induction immunosuppression in pancreas transplantation with anti-interleukin-2 receptor antibody versus anti-thymocyte globulin.Synthesis, and Characterization, and Evaluation of Cellular Effects of the FOL-PEG-g-PEI-GAL Nanoparticles as a Potential Non-Viral Vector for Gene Delivery
P2860
Q30217177-79592274-B692-4B28-B627-C8921E5D83DBQ33553646-96F1661C-E154-4E3F-84DF-8649CB4E10D4Q33671675-1BE5981A-F335-4224-96D8-4BD9B86C36F6Q33911488-ACC727E7-A44B-4E73-9557-88A3D75A05D7Q34079568-F16A5CD2-941C-4386-A02C-233959902430Q34601238-5EFE82E8-D5CE-467D-BB2B-E1335AB8A91EQ34710895-D4704E29-01AF-4F79-A429-6A2D27E8B549Q35194002-D253D1C0-7506-48FD-BF1A-281C415A7B1DQ36153387-9170E141-9653-46FE-B6BD-73FF044C1E8EQ36483682-18C354DA-828F-4AA1-A314-6D8209C2832BQ36663422-58077220-BA37-4DB3-B114-3462CFB39C6DQ36736462-EE0EFBDC-3790-44A5-890E-EC1CD82A4EE2Q36786243-24808C94-24DE-4621-B967-48048383E1EBQ38107432-D4CAC96A-A0F3-484C-A2C7-20FCB91DB9CBQ38999003-71F0215A-8C3F-4860-8D5A-8A5DDE12DBBFQ40315007-EFC3B672-260C-4DAE-BBB6-15D5CE9A9074Q41767106-8B9FF893-19A8-429A-9F3B-2DEF6A65A665Q41847338-7A2F4683-6793-4688-B4F9-8099E7A6D826Q51975777-0CD3A25C-B9C3-47AF-84DA-C2D234857B7FQ58652268-11F1257F-8752-4787-8E0E-37058941A273
P2860
Genetic, cellular and immune approaches to disease therapy: past and future.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Genetic, cellular and immune approaches to disease therapy: past and future.
@ast
Genetic, cellular and immune approaches to disease therapy: past and future.
@en
type
label
Genetic, cellular and immune approaches to disease therapy: past and future.
@ast
Genetic, cellular and immune approaches to disease therapy: past and future.
@en
prefLabel
Genetic, cellular and immune approaches to disease therapy: past and future.
@ast
Genetic, cellular and immune approaches to disease therapy: past and future.
@en
P356
P1433
P1476
Genetic, cellular and immune approaches to disease therapy: past and future.
@en
P2888
P304
P356
10.1038/NM990
P407
P50
P577
2004-02-01T00:00:00Z